eli lilly glp-1 supply news today What's next for innovation: A primer on the race reshaping pharma and chronic disease care New clinical trial data from
Description
doi: 10.1038/s41467-017-02488-y
Something had to give.
Furthermore, these agents modulate inflammation, reduce apoptosis, and improve stem cell functions even under diabetic or inflammatory conditions
What do you think will be the biggest growth catalyst for the GLP-1 market over the next decade
